0
Cardiovascular Disease |

Quality of Life and Health Status After Chinese Herb Treatment in Stable Angina Patients

Shihan Wang*, MD; Ji Li, MD; Xingjiang Xiong, MD; Yong Ye, MD; Qingyong He, MD; Jie Wang, MD
Author and Funding Information

Guang An Men Hospital, China Academy of Chinese Medical Science, Beijing, China


Chest. 2012;142(4_MeetingAbstracts):85A. doi:10.1378/chest.1389601
Text Size: A A A
Published online

Abstract

SESSION TYPE: Arrhythmia and Coronary Artery Disease

PRESENTED ON: Monday, October 22, 2012 at 11:15 AM - 12:30 PM

PURPOSE: To evaluate the long term quality of life and health status in patients with stable angina after Chinese herb (made from Chinese sage and trichosanthes) treatment.

METHODS: We performed a prospective multi-center placebo controlled trial to evaluate the long term quality of life after Chinese herb treatment. The Chinese herb are made from Chinese sage and trichosanthes. All the patients got standardized therapy included Aspirin, simvastatin and isosorbide dinitrate according to the guideline for the management of stable angina. On the top of these standardized treatments, 66 patients got Chinese herb treatment and the other half got placebo. All patients were followed up for one year. The primary outcome was the change of SF-36 and Seattle Angina Questionnaire (SAQ).

RESULTS: A total of 132 patients from four participated centers were enrolled in the study from 2008 to 2009. No significant differences were observed in the baseline characteristics and comorbidities between two groups. The mean age is 61±9 in herb group vs. 62±8 in placebo controls, 74% male versus 72%, hypertension present 50% vs. 61% and hyperlipedimia 32% vs. 30% ,respectively. The score of short form-36 (SF-36) increased significantly from 58±10 to 77±15 (P<0.01) in herb treatment group but no significant increase in control group from 58±11 to 67±12(p=0.09). The SAQ score increased significantly after one year treatment in both groups. While the increase of SAQ is significantly higher in herb treatment group (35±15)when compared to the placebo controls (15±10).

CONCLUSIONS: The Chinese herb treatment can significantly improve the quality of life in the stable angina patients when compared to placebo controls as assessed by SF-36 and SAQ.

CLINICAL IMPLICATIONS: This trial indicates that integrated therapy included both Chinese Herb and standardized western medicine can improve one year health status of stable angina patients. The nature herb should be considered as an important adjutant therapy for stable angina patients.

DISCLOSURE: The following authors have nothing to disclose: Shihan Wang, Ji Li, Xingjiang Xiong, Yong Ye, Qingyong He, Jie Wang

No Product/Research Disclosure Information

Guang An Men Hospital, China Academy of Chinese Medical Science, Beijing, China

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543